Latest filing published 21 Dec 2018 for ENDOCYTE INC, €478k.
Filing timeline
BuySaleInsider track record
Katherine Parker: trading record in brief
Katherine Parker is a declared insider of Endocyte Inc, with filings sourced from SEC (Form 4). We count 13 filings; the first trade dates from 4 February 2016 and the latest from 21 December 2018.
Every open-market trade on record is a sale: 2 sales worth €183k. The rest of the record consists of 4 share grants. In 2018 alone, the filings show no purchases and 2 sales.
The record was last updated on 21 December 2018 with a transaction (€478k) in Endocyte Inc. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Katherine Parker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,797 shares@ US$24.0033.3% of flowCommon StockSEC:0001104659-18-074355:1
- 3,125 shares@ US$24.004.6% of flowCommon StockSEC:0001104659-18-074355:2
- 9,375 shares@ US$24.0013.7% of flowCommon StockSEC:0001104659-18-074355:3
- 15,000 shares@ US$24.0021.9% of flowCommon StockSEC:0001104659-18-074355:4
- 12,500 shares@ US$24.0018.3% of flowCommon StockSEC:0001104659-18-074355:5
- 1,200 shares@ US$24.001.8% of flowCommon StockSEC:0001104659-18-074355:6
- 8,229 shares0Common StockSEC:0001104659-18-074355:0
- 6,771 shares@ US$15.556.4% of flowCommon StockSEC:0001179110-18-012086:0
- 12,500 shares0Common StockSEC:0001179110-18-001813:0
- 30,000 shares0Common StockSEC:0001179110-17-013186:0
- 12,500 shares0Common StockSEC:0001179110-17-001596:0
- 6,250 sharesCommon StockSEC:0001144204-16-079694:0
12 of 12 declarations